3-D printed ovaries may restore fertility in cancer survivors

Image
IANS New York
Last Updated : May 17 2017 | 2:57 PM IST

The new world of three-dimensional (3-D) printed organs now includes implanted ovary structures that can actually ovulate and may help childhood cancer survivors produce healthy children, a research has showed.

The bioprosthetic ovaries, constructed of 3-D printed scaffolds that house immature eggs, was found to successfully boost hormone production as well as restore fertility in mice.

"This research shows these bioprosthetic ovaries have long-term, durable function," said Teresa K. Woodruff, a reproductive scientist at the Northwestern University in the US.

Importantly, the architecture of the scaffold and the material, or "ink", that was used in the bioprosthetic ovaries are different from other 3-D printed structures, added Ramille Shah, Assistant Professor at the Northwestern University.

The material used was gelatin -- a biological hydrogel made from broken-down collagen and is safe to use in humans.

The bioprosthetic ovaries may help restore fertility and hormone production in women who have undergone adult cancer treatments or those who survived childhood cancer and now have increased risks of infertility and hormone-based developmental issues, the researchers said, in the paper published in the journal Nature Communications.

"What happens with some of our cancer patients is that their ovaries don't function at a high enough level and they need to use hormone replacement therapies in order to trigger puberty," explained Monica Laronda, Assistant Professor at the Ann and Robert H. Lurie Children's Hospital in Illinois, US.

"The purpose of this scaffold is to recapitulate how an ovary would function. We're thinking big picture, meaning every stage of the girl's life, so puberty through adulthood to a natural menopause," Laronda said.

Additionally, the successful creation of 3-D printed implants to replace complex soft tissue could also significantly impact future work in soft tissue regenerative medicine, the researchers stated.

--IANS

rt/in/vt

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 17 2017 | 2:50 PM IST

Next Story